Tirzepatide → Pancreatitis — Null result

← All findings ⬇ Download signed audit packet

Ledger entry · null-result

Tirzepatide → Pancreatitis — Null result

Drug: tirzepatide · AE: Pancreatitis

Caliper validation of the submitted claim (drug=tirzepatide, AE=Pancreatitis). COEXPOSURE_CONFOUNDED — ? at 0% co-exposure; signal not attributable to tirzepatide alone

Disproportionality

PRR: 2.3794457524119603 (95% CI 2.10–2.70)
Yates χ²: 194.72235703087375
Cases (case-drug + AE): n = 245
Verdict: COEXPOSURE_CONFOUNDED — ? at 0% co-exposure; signal not attributable to tirzepatide alone

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: 9da24e5ee0c4d5650b0c23b2afef181f140c2949